{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:08:37Z","timestamp":1762524517641,"version":"build-2065373602"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05253-y","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:50:24Z","timestamp":1762519824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and associated factors of comorbidities among hypertensive patients in Northwest Ethiopia, 2024"],"prefix":"10.1186","volume":"25","author":[{"given":"Baye","family":"Ashenef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayu Wondmneh","family":"Yimenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enatnesh Essa","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derese","family":"Sinamaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gelagey","family":"Baye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zigale Hibstu","family":"Teffera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adane","family":"Adugna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyew Fenta","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temesgen","family":"Baylie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"5253_CR1","doi-asserted-by":"crossref","unstructured":"Deepshikha MP, Monika, Jhawat V, Shekhar S, Dutt R, et al. An overview of hypertension: pathophysiology, risk factors, and modern management. Curr Hypertens Rev. 2025;21(2):64\u201381.","DOI":"10.2174\/0115734021349254250224074832"},{"issue":"12","key":"5253_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S1474-4422(23)00420-9","volume":"22","author":"N The Lancet","year":"2023","unstructured":"The Lancet N. The global challenge of hypertension. Lancet Neurol. 2023;22(12):1087.","journal-title":"Lancet Neurol"},{"key":"5253_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.gerinurse.2023.05.012","volume":"52","author":"AMA Ismail","year":"2023","unstructured":"Ismail AMA, Saif H, Taha MM. Effect of alternate nostril breathing exercise on autonomic functions, ocular hypertension, and quality of life in elderly with systemic hypertension and high-tension primary open-angle glaucoma. Geriatr Nurs. 2023;52:91\u20137.","journal-title":"Geriatr Nurs"},{"key":"5253_CR4","unstructured":"Weir MR, Hypertension. MSD Manual Professional Edition: MSD Manual; 2025 [updated 2025\/02]. Available from: https:\/\/www.msdmanuals.com\/professional\/cardiovascular-disorders\/hypertension\/hypertension."},{"key":"5253_CR5","first-page":"1326","volume":"20","author":"S Fatima","year":"2021","unstructured":"Fatima S, Mahmood S. Combatting a silent killer - the importance of self-screening of blood pressure from an early age. Excli J. 2021;20:1326\u20137.","journal-title":"Excli J"},{"key":"5253_CR6","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.2147\/OPTH.S408171","volume":"17","author":"B Ashenef","year":"2023","unstructured":"Ashenef B, Diress M, Yeshaw Y, Dagnew B, Gela YY, Akalu Y, et al. Visual impairment and its associated factors among hypertensive patients in Amhara region referral Hospitals, Ethiopia. Clin Ophthalmol. 2023;17:3149\u201361.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"5253_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HCO.0000000000000298","volume":"31","author":"PL Shrestha","year":"2016","unstructured":"Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with hypertension. Curr Opin Cardiol. 2016;31(4):376\u201380.","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"5253_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/areh.2023.127506","volume":"37","author":"S Elsheikh","year":"2023","unstructured":"Elsheikh S, Elnahas N, Wahab Soliman A, Ismail A. Effect of bhramari versus Sheetali Pranayama on quality of life in hypertensive patients. Adv Rehabilitation. 2023;37(2):1\u20138.","journal-title":"Adv Rehabilitation"},{"issue":"50","key":"5253_CR9","doi-asserted-by":"publisher","first-page":"e1959","DOI":"10.1097\/MD.0000000000001959","volume":"94","author":"AM Sarki","year":"2015","unstructured":"Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in Low- and Middle-Income countries: a systematic review and Meta-Analysis. Medicine. 2015;94(50):e1959.","journal-title":"Medicine"},{"issue":"5","key":"5253_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, Okura A, Hoshide S, Mogi M. The WHO global report 2023 on hypertension warning the emerging hypertension burden in Globe and its treatment strategy. Hypertens Res. 2024;47(5):1099\u2013102.","journal-title":"Hypertens Res"},{"issue":"2","key":"5253_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertens (Dallas Tex: 1979). 2020;75(2):285\u201392.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"8","key":"5253_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.mayocp.2021.06.015","volume":"96","author":"DL Joyce","year":"2021","unstructured":"Joyce DL. The invisible silent killer. Mayo Clin Proc. 2021;96(8):2022\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"5253_CR13","first-page":"e42616","volume":"15","author":"GK Ghodeshwar","year":"2023","unstructured":"Ghodeshwar GK, Dube A, Khobragade D. Impact of lifestyle modifications on cardiovascular health: a narrative review. Cureus. 2023;15(7):e42616.","journal-title":"Cureus"},{"key":"5253_CR14","doi-asserted-by":"crossref","unstructured":"Zappa M, Golino M, Verdecchia P, Angeli F. Genetics of hypertension: from monogenic analysis to getomics. J Cardiovasc Dev Dis. 2024;11(5).","DOI":"10.3390\/jcdd11050154"},{"issue":"1","key":"5253_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-025-03923-4","volume":"23","author":"S Wu","year":"2025","unstructured":"Wu S, Wang Y, Wang J, Feng J, Li F, Lin L, et al. Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: insights from the Kailuan cohort. BMC Med. 2025;23(1):80.","journal-title":"BMC Med"},{"issue":"1","key":"5253_CR16","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1038\/s41598-023-29451-w","volume":"13","author":"F Sadabadi","year":"2023","unstructured":"Sadabadi F, Darroudi S, Esmaily H, Asadi Z, Ferns GA, Mohammadpour AH, et al. The importance of sleep patterns in the incidence of coronary heart disease: a 6-year prospective study in Mashhad, Iran. Sci Rep. 2023;13(1):2903.","journal-title":"Sci Rep"},{"key":"5253_CR17","first-page":"71","volume-title":"Hypertension (Fourth Edition)","author":"JE Hall","year":"2024","unstructured":"Hall JE, Omoto ACM, Wang Z, Mouton A, Li X, Hall ME. 5 - Pathophysiology of hypertension. In: Bakris GL, Sorrentino MJ, Laffin LJ, editors. Hypertension (Fourth Edition). New Delhi: Elsevier; 2024. p. 71\u201386."},{"issue":"9","key":"5253_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/heart.89.9.1104","volume":"89","author":"J Mayet","year":"2003","unstructured":"Mayet J, Hughes A. Cardiac and vascular pathophysiology in hypertension. Heart. 2003;89(9):1104\u20139.","journal-title":"Heart"},{"key":"5253_CR19","doi-asserted-by":"publisher","first-page":"1003852","DOI":"10.3389\/fcvm.2022.1003852","volume":"9","author":"J Ma","year":"2022","unstructured":"Ma J, Chen X. Advances in pathogenesis and treatment of essential hypertension. Front Cardiovasc Med. 2022;9:1003852.","journal-title":"Front Cardiovasc Med"},{"key":"5253_CR20","doi-asserted-by":"publisher","first-page":"391762","DOI":"10.4061\/2011\/391762","volume":"2011","author":"S Horita","year":"2011","unstructured":"Horita S, Seki G, Yamada H, Suzuki M, Koike K, Fujita T. Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens. 2011;2011:391762.","journal-title":"Int J Hypertens"},{"issue":"1","key":"5253_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40885-023-00258-1","volume":"29","author":"HL Kim","year":"2023","unstructured":"Kim HL. Arterial stiffness and hypertension. Clin Hypertens. 2023;29(1):31.","journal-title":"Clin Hypertens"},{"key":"5253_CR22","first-page":"635","volume-title":"Introduction, types, causes, and complications","author":"Y Kokubo","year":"2015","unstructured":"Kokubo Y, Iwashima Y, Kamide K, Hypertension. Introduction, types, causes, and complications. Pathophysiology and Pharmacotherapy of Cardiovascular Disease: Springer; 2015. p. 635\u201353."},{"issue":"1","key":"5253_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrneph.2012.260","volume":"9","author":"PA Sarafidis","year":"2013","unstructured":"Sarafidis PA, Georgianos P, Bakris GL. Resistant hypertension\u2014its identification and epidemiology. Nat Rev Nephrol. 2013;9(1):51\u20138.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"5253_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrcardio.2011.115","volume":"8","author":"G Mancia","year":"2011","unstructured":"Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Reviews Cardiol. 2011;8(12):686\u201393.","journal-title":"Nat Reviews Cardiol"},{"issue":"2","key":"5253_CR25","doi-asserted-by":"publisher","first-page":"100135","DOI":"10.1016\/j.aggp.2025.100135","volume":"2","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Li H. Study on the risk of comorbid hypertension in multiple chronic diseases. Archives Gerontol Geriatr Plus. 2025;2(2):100135.","journal-title":"Archives Gerontol Geriatr Plus"},{"issue":"1","key":"5253_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12872-025-04733-5","volume":"25","author":"RK Benli","year":"2025","unstructured":"Benli RK, Yasarer \u00d6, Mete E, Kili\u00c7 BB. The relationship between comorbidities, physical inactivity, kinesiophobia and physical performance in hypertensive individuals: a cross-sectional study. BMC Cardiovasc Disord. 2025;25(1):279.","journal-title":"BMC Cardiovasc Disord"},{"key":"5253_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HCO.0000000000000302","volume":"31","author":"H Ventura","year":"2016","unstructured":"Ventura H, Lavie C. Impact of comorbidities in hypertension. Curr Opin Cardiol. 2016;31(4):374\u20135.","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"5253_CR28","doi-asserted-by":"publisher","first-page":"e1003674","DOI":"10.1371\/journal.pmed.1003674","volume":"18","author":"J Tran","year":"2021","unstructured":"Tran J, Norton R, Canoy D, Ayala Solares JR, Conrad N, Nazarzadeh M, et al. Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. PLoS Med. 2021;18(6):e1003674.","journal-title":"PLoS Med"},{"issue":"4","key":"5253_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/HCO.0000000000000302","volume":"31","author":"HO Ventura","year":"2016","unstructured":"Ventura HO, Lavie CJ. Impact of comorbidities in hypertension. Curr Opin Cardiol. 2016;31(4):374\u20135.","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"5253_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7150\/ijms.16974","volume":"14","author":"J Wang","year":"2017","unstructured":"Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201\u201312.","journal-title":"Int J Med Sci"},{"issue":"2","key":"5253_CR31","doi-asserted-by":"publisher","first-page":"e14965","DOI":"10.1111\/jch.14965","volume":"27","author":"S Zhang","year":"2025","unstructured":"Zhang S, Yang Y, Chen X, Fan L, Wu J, Liu X, et al. Diabetes mellitus and hyperlipidemia status among hypertensive patients in the community and influencing factors analysis of blood pressure control. J Clin Hypertens (Greenwich Conn). 2025;27(2):e14965.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"issue":"5","key":"5253_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4070\/kcj.2016.46.5.672","volume":"46","author":"J Noh","year":"2016","unstructured":"Noh J, Kim HC, Shin A, Yeom H, Jang SY, Lee JH, et al. Prevalence of comorbidity among people with hypertension: the Korea National health and nutrition examination survey 2007\u20132013. Korean Circulation J. 2016;46(5):672\u201380.","journal-title":"Korean Circulation J"},{"issue":"1","key":"5253_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12889-022-12562-w","volume":"22","author":"A Mannan","year":"2022","unstructured":"Mannan A, Akter KM, Akter F, Chy NUHA, Alam N, Pinky SD, et al. Association between comorbidity and health-related quality of life in a hypertensive population: a hospital-based study in Bangladesh. BMC Public Health. 2022;22(1):181.","journal-title":"BMC Public Health"},{"key":"5253_CR34","doi-asserted-by":"publisher","first-page":"5515832","DOI":"10.1155\/2021\/5515832","volume":"2021","author":"A Hunegnaw","year":"2021","unstructured":"Hunegnaw A, Mekonnen HS, Techane MA, Agegnehu CD. Prevalence and associated factors of chronic kidney disease among adult hypertensive patients at Northwest Amhara referral Hospitals, Northwest Ethiopia, 2020. Int J Hypertens. 2021;2021:5515832.","journal-title":"Int J Hypertens"},{"issue":"Suppl 1","key":"5253_CR35","first-page":"S62","volume":"33","author":"Diagnosis and classification of diabetes mellitus","year":"2010","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62\u20139.","journal-title":"Diabetes Care"},{"issue":"13","key":"5253_CR36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294\u2013304.","journal-title":"JAMA"},{"key":"5253_CR37","unstructured":"Davidson MH, Altenburg M, Dyslipidemia MSD, Manual Professional, Edition. MSD Manual; 2025 [updated 2025\/05]. Available from: https:\/\/www.msdmanuals.com\/professional\/endocrine-and-metabolic-disorders\/lipid-disorders\/dyslipidemia."},{"key":"5253_CR38","doi-asserted-by":"crossref","unstructured":"Ashenef B, Yimenu BW, Osman EE, Sinamaw D, Baye G, Teffera ZH, et al. Excessive body weight and its contributing factors in visually impaired patients in Northwest Ethiopia, 2024. Front Endocrinol. 2025;16:1514308.","DOI":"10.3389\/fendo.2025.1514308"},{"issue":"19","key":"5253_CR39","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","volume":"320","author":"KL Piercy","year":"2018","unstructured":"Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020\u20138.","journal-title":"JAMA"},{"key":"5253_CR40","unstructured":"CDC. NCHS, National Health Interview Survey, Special Topics, Adult Tobacco Use Information. 2019. https:\/\/www.cdc.gov\/nchs\/nhis\/tobacco\/tobacco_glossaryhtm."},{"key":"5253_CR41","unstructured":"Topics CDCNCHSNHISS. Adult Alcohol Use. 2020. https:\/\/archive.cdc.gov\/www_cdc_gov\/nchs\/nhis\/alcohol\/alcohol_glossary.htm."},{"issue":"1","key":"5253_CR42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1186\/s12889-025-22868-0","volume":"25","author":"F Kamrani","year":"2025","unstructured":"Kamrani F, Imannezhad M, Jafari M, Mahdavizadeh V, Bajgiran MM, Moohebati M, et al. Association between sleep duration and long-term changes in novel anthropometric and atherogenic indices: a cohort study. BMC Public Health. 2025;25(1):1611.","journal-title":"BMC Public Health"},{"key":"5253_CR43","doi-asserted-by":"publisher","first-page":"1606014","DOI":"10.3389\/ijph.2023.1606014","volume":"68","author":"S Darroudi","year":"2023","unstructured":"Darroudi S, Eslamiyeh M, Jaber Al-Fayyadh KK, Zamiri Bidary M, Danesteh S, Hassanzadeh Gouji A, et al. Prognostic factors associated with sleep duration: serum Pro-Oxidant\/Antioxidant balance and superoxide dismutase 1 as oxidative stress markers and Anxiety\/Depression. Int J Public Health. 2023;68:1606014.","journal-title":"Int J Public Health"},{"issue":"1","key":"5253_CR44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1186\/s12889-025-22828-8","volume":"25","author":"TM Yirga Gk, Aytenew","year":"2025","unstructured":"Yirga Gk, Aytenew TM, Kassaw A, Hiruy EG, Shiferaw K, Baye AA, et al. Chronic kidney disease among patients with hypertension in sub-Saharan africa: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):1603.","journal-title":"BMC Public Health"},{"issue":"9","key":"5253_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1524-6175.2005.04130.x","volume":"7","author":"LG Navar","year":"2005","unstructured":"Navar LG. The role of the kidneys in hypertension. J Clin Hypertens (Greenwich Conn). 2005;7(9):542\u20139.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"key":"5253_CR46","doi-asserted-by":"crossref","unstructured":"Seravalle G, Grassi G. In: Pappachan JM, Fernandez CJ, editors. Chapter 5 - Renin\u2013angiotensin\u2013aldosterone system and blood pressure regulation. Endocrine Hypertension: Academic; 2023. p. 63\u201375.","DOI":"10.1016\/B978-0-323-96120-2.00002-9"},{"issue":"9","key":"5253_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11883-023-01132-z","volume":"25","author":"E D\u0105browska","year":"2023","unstructured":"D\u0105browska E, Narkiewicz K. Hypertension and dyslipidemia: the two partners in Endothelium-Related crime. Curr Atheroscler Rep. 2023;25(9):605\u201312.","journal-title":"Curr Atheroscler Rep"},{"key":"5253_CR48","doi-asserted-by":"crossref","unstructured":"Higashi Y. Endothelial function in dyslipidemia: roles of LDL-Cholesterol, HDL-Cholesterol and triglycerides. Cells. 2023;12(9):1293.","DOI":"10.3390\/cells12091293"},{"key":"5253_CR49","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol. 2023;14:1149239.","journal-title":"Front Endocrinol"},{"key":"5253_CR50","first-page":"413","volume-title":"Hypertension (Fourth Edition)","author":"ME Hall","year":"2024","unstructured":"Hall ME, Omoto ACM, Do Carmo JM, Da Silva AA, Hall JE. 37 - Obesity and hypertension: pathophysiology and treatment. In: Bakris GL, Sorrentino MJ, Laffin LJ, editors. Hypertension (Fourth Edition). New Delhi: Elsevier; 2024. p. 413\u201326."},{"issue":"4","key":"5253_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1467-789X.2001.00044.x","volume":"2","author":"T Pischon","year":"2001","unstructured":"Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Reviews: Official J Int Association Study Obes. 2001;2(4):275\u201380.","journal-title":"Obes Reviews: Official J Int Association Study Obes"},{"issue":"6","key":"5253_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrendo.2014.44","volume":"10","author":"VG DeMarco","year":"2014","unstructured":"DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Reviews Endocrinol. 2014;10(6):364\u201376.","journal-title":"Nat Reviews Endocrinol"},{"issue":"7","key":"5253_CR53","first-page":"e3032","volume":"10","author":"AH Ans","year":"2018","unstructured":"Ans AH, Anjum I, Satija V, Inayat A, Asghar Z, Akram I, et al. Neurohormonal regulation of appetite and its relationship with stress: a mini literature review. Cureus. 2018;10(7):e3032.","journal-title":"Cureus"},{"issue":"5","key":"5253_CR54","first-page":"575","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575\u201384.","journal-title":"Can J Cardiol"},{"issue":"4","key":"5253_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1751-7176.2011.00434.x","volume":"13","author":"AN Long","year":"2011","unstructured":"Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich Conn). 2011;13(4):244\u201351.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"issue":"1","key":"5253_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12872-023-03250-7","volume":"23","author":"J Wu","year":"2023","unstructured":"Wu J, Han X, Sun D, Zhang J, Li J, Qin G, et al. Age-specific association of stage of hypertension at diagnosis with cardiovascular and all-cause mortality among elderly patients with hypertension: a cohort study. BMC Cardiovasc Disord. 2023;23(1):270.","journal-title":"BMC Cardiovasc Disord"},{"issue":"23","key":"5253_CR57","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American heart association. Circulation. 2016;134(23):e535\u201378.","journal-title":"Circulation"},{"issue":"1","key":"5253_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mpmed.2020.10.011","volume":"49","author":"J Preston","year":"2021","unstructured":"Preston J, Biddell B. The physiology of ageing and how these changes affect older people. Medicine. 2021;49(1):1\u20135.","journal-title":"Medicine"},{"issue":"8","key":"5253_CR59","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1113\/JP270538","volume":"594","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061\u201373.","journal-title":"J Physiol"},{"issue":"6","key":"5253_CR60","first-page":"434","volume":"135","author":"GR Boss","year":"1981","unstructured":"Boss GR, Seegmiller JE. Age-related physiological changes and their clinical significance. Western J Med. 1981;135(6):434\u201340.","journal-title":"Western J Med"},{"key":"5253_CR61","doi-asserted-by":"crossref","unstructured":"Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy Management in Older Patients. Mayo Clinic Proceedings. 2021;96(1):242\u2009\u2013\u200956.","DOI":"10.1016\/j.mayocp.2020.06.012"},{"issue":"10","key":"5253_CR62","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/bcp.14074","volume":"86","author":"R Roller-Wirnsberger","year":"2020","unstructured":"Roller-Wirnsberger R, Thurner B, Pucher C, Lindner S, Wirnsberger GH. The clinical and therapeutic challenge of treating older patients in clinical practice. Br J Clin Pharmacol. 2020;86(10):1904\u201311.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"5253_CR63","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1186\/s12889-019-7762-5","volume":"19","author":"P Maresova","year":"2019","unstructured":"Maresova P, Javanmardi E, Barakovic S, Barakovic Husic J, Tomsone S, Krejcar O, et al. Consequences of chronic diseases and other limitations associated with old age \u2013 a scoping review. BMC Public Health. 2019;19(1):1431.","journal-title":"BMC Public Health"},{"key":"5253_CR64","doi-asserted-by":"publisher","first-page":"948707","DOI":"10.3389\/fcvm.2022.948707","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Gao X, Jia HY, Li FR, Ye H. Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: a large prospective cohort study. Front Cardiovasc Med. 2022;9:948707.","journal-title":"Front Cardiovasc Med"},{"issue":"3 Suppl 2","key":"5253_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1524-6175.2003.02464.x","volume":"5","author":"WC Cushman","year":"2003","unstructured":"Cushman WC. The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression. J Clin Hypertens (Greenwich Conn). 2003;5(3 Suppl 2):14\u201322.","journal-title":"J Clin Hypertens (Greenwich Conn)"},{"key":"5253_CR66","doi-asserted-by":"crossref","unstructured":"Cody RJ. The sympathetic nervous system and the renin\u2013angiotensin\u2013aldosterone system in cardiovascular disease. Am J Cardiol. 1997;80(9):9J\u201314J.","DOI":"10.1016\/S0002-9149(97)00832-1"},{"issue":"5","key":"5253_CR67","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","volume":"50","author":"JL Rains","year":"2011","unstructured":"Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50(5):567\u201375.","journal-title":"Free Radic Biol Med"},{"key":"5253_CR68","doi-asserted-by":"crossref","unstructured":"Vacca A, Bulfone L, Cicco S, Brosolo G, Da Porto A, Soardo G, et al. Alcohol intake and arterial hypertension: retelling of a multifaceted story. Nutrients. 2023;15(4):958.","DOI":"10.3390\/nu15040958"},{"issue":"13","key":"5253_CR69","doi-asserted-by":"publisher","first-page":"e009698","DOI":"10.1161\/JAHA.118.009698","volume":"7","author":"S Bell","year":"2018","unstructured":"Bell S. Alcohol consumption, hypertension, and cardiovascular health across the life course: there is no such thing as a one-size\u2010fits\u2010all approach. J Am Heart Association. 2018;7(13):e009698.","journal-title":"J Am Heart Association"},{"issue":"2","key":"5253_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.35946\/arcr.v38.2.06","volume":"38","author":"MR Piano","year":"2017","unstructured":"Piano MR. Alcohol\u2019s effects on the cardiovascular system. Alcohol Research: Curr Reviews. 2017;38(2):219\u201341.","journal-title":"Alcohol Research: Curr Reviews"},{"issue":"11","key":"5253_CR71","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2337\/diacare.23.11.1630","volume":"23","author":"RA Bell","year":"2000","unstructured":"Bell RA, Mayer-Davis EJ, Martin MA, D\u2019Agostino RB Jr., Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the insulin resistance and atherosclerosis study. Diabetes Care. 2000;23(11):1630\u20136.","journal-title":"Diabetes Care"},{"key":"5253_CR72","doi-asserted-by":"publisher","first-page":"E02","DOI":"10.5888\/pcd22.240149","volume":"22","author":"CG Chapman","year":"2025","unstructured":"Chapman CG, Schroeder MC, Marcussen B, Carr LJ. Identifying patients at risk for cardiometabolic and chronic diseases by using the exercise vital sign to screen for physical inactivity. Prev Chronic Dis. 2025;22:E02.","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"5253_CR73","first-page":"1","volume":"61","author":"R Pi\u0161ot","year":"2022","unstructured":"Pi\u0161ot R. Physical Inactivity - the human health\u2019s greatest enemy. Zdravstveno Varstvo. 2022;61(1):1\u20135.","journal-title":"Zdravstveno Varstvo"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05253-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:03:31Z","timestamp":1762524211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05253-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5253"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05253-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed relevant ethical guidelines and regulations. Ethical clearance was obtained from the Institutional Review Committee of the Amhara Public Health Institute (Ref. No APHI 12\/2081) and the respective referral hospitals, following confirmation that the Helsinki Declaration was upheld. Written informed consent, supported by verbal agreement, was obtained from all participants. Confidentiality and privacy were maintained, with no personal identifiers recorded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"788"}}